[DPHARMA] QoQ Cumulative Quarter Result on 31-Dec-2011 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
22-Feb-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2011
Quarter
31-Dec-2011 [#4]
Profit Trend
QoQ- 31.05%
YoY- -6.85%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Revenue 99,932 70,412 36,057 138,132 105,096 68,329 32,984 108.95%
PBT 26,298 17,906 8,869 34,728 26,892 17,166 7,875 122.92%
Tax -6,281 -4,331 -2,161 -8,023 -6,515 -4,310 -1,951 117.56%
NP 20,017 13,575 6,708 26,705 20,377 12,856 5,924 124.67%
-
NP to SH 20,017 13,575 6,708 26,705 20,377 12,856 5,924 124.67%
-
Tax Rate 23.88% 24.19% 24.37% 23.10% 24.23% 25.11% 24.77% -
Total Cost 79,915 56,837 29,349 111,427 84,719 55,473 27,060 105.43%
-
Net Worth 167,965 162,400 170,824 163,783 162,405 154,105 162,320 2.29%
Dividend
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Div - 4,858 - 24,983 - 4,859 - -
Div Payout % - 35.79% - 93.56% - 37.80% - -
Equity
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Net Worth 167,965 162,400 170,824 163,783 162,405 154,105 162,320 2.29%
NOSH 138,814 138,803 138,881 138,799 138,807 138,833 138,735 0.03%
Ratio Analysis
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
NP Margin 20.03% 19.28% 18.60% 19.33% 19.39% 18.81% 17.96% -
ROE 11.92% 8.36% 3.93% 16.31% 12.55% 8.34% 3.65% -
Per Share
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
RPS 71.99 50.73 25.96 99.52 75.71 49.22 23.77 108.90%
EPS 14.42 9.78 4.83 19.24 14.68 9.26 4.27 124.59%
DPS 0.00 3.50 0.00 18.00 0.00 3.50 0.00 -
NAPS 1.21 1.17 1.23 1.18 1.17 1.11 1.17 2.26%
Adjusted Per Share Value based on latest NOSH - 138,793
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
RPS 10.39 7.32 3.75 14.36 10.93 7.10 3.43 108.93%
EPS 2.08 1.41 0.70 2.78 2.12 1.34 0.62 123.60%
DPS 0.00 0.51 0.00 2.60 0.00 0.51 0.00 -
NAPS 0.1746 0.1688 0.1776 0.1703 0.1688 0.1602 0.1687 2.31%
Price Multiplier on Financial Quarter End Date
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Date 28/09/12 29/06/12 30/03/12 30/12/11 30/09/11 30/06/11 31/03/11 -
Price 2.36 2.23 2.40 2.02 2.10 2.34 2.35 -
P/RPS 3.28 4.40 9.24 2.03 2.77 4.75 9.88 -51.95%
P/EPS 16.37 22.80 49.69 10.50 14.31 25.27 55.04 -55.34%
EY 6.11 4.39 2.01 9.52 6.99 3.96 1.82 123.71%
DY 0.00 1.57 0.00 8.91 0.00 1.50 0.00 -
P/NAPS 1.95 1.91 1.95 1.71 1.79 2.11 2.01 -1.99%
Price Multiplier on Announcement Date
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Date 23/11/12 16/08/12 17/05/12 22/02/12 21/11/11 18/08/11 25/05/11 -
Price 2.28 2.38 2.38 2.12 2.10 2.22 2.57 -
P/RPS 3.17 4.69 9.17 2.13 2.77 4.51 10.81 -55.76%
P/EPS 15.81 24.34 49.28 11.02 14.31 23.97 60.19 -58.88%
EY 6.32 4.11 2.03 9.08 6.99 4.17 1.66 143.22%
DY 0.00 1.47 0.00 8.49 0.00 1.58 0.00 -
P/NAPS 1.88 2.03 1.93 1.80 1.79 2.00 2.20 -9.92%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment